These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

327 related items for PubMed ID: 8232033

  • 1. Pseudomonas aeruginosa bacteraemia. Is pancreatobiliary disease a risk factor?
    Chen SC, Lawrence RH, Byth K, Sorrell TC.
    Med J Aust; 1993 Nov 01; 159(9):592-7. PubMed ID: 8232033
    [Abstract] [Full Text] [Related]

  • 2. Treatment and outcome of Pseudomonas aeruginosa bacteraemia: an antibiotic pharmacodynamic analysis.
    Zelenitsky SA, Harding GK, Sun S, Ubhi K, Ariano RE.
    J Antimicrob Chemother; 2003 Oct 01; 52(4):668-74. PubMed ID: 12951354
    [Abstract] [Full Text] [Related]

  • 3. Epidemiology and outcome of Pseudomonas aeruginosa bacteremia, with special emphasis on the influence of antibiotic treatment. Analysis of 189 episodes.
    Vidal F, Mensa J, Almela M, Martínez JA, Marco F, Casals C, Gatell JM, Soriano E, Jimenez de Anta MT.
    Arch Intern Med; 1996 Oct 14; 156(18):2121-6. PubMed ID: 8862105
    [Abstract] [Full Text] [Related]

  • 4. Clinical features and outcome of patients with community-acquired Pseudomonas aeruginosa bacteraemia.
    Kang CI, Kim SH, Park WB, Lee KD, Kim HB, Kim EC, Oh MD, Choe KW.
    Clin Microbiol Infect; 2005 May 14; 11(5):415-8. PubMed ID: 15819873
    [Abstract] [Full Text] [Related]

  • 5. Clinical features and therapeutic implications of 104 episodes of monomicrobial Aeromonas bacteraemia.
    Ko WC, Lee HC, Chuang YC, Liu CC, Wu JJ.
    J Infect; 2000 May 14; 40(3):267-73. PubMed ID: 10908022
    [Abstract] [Full Text] [Related]

  • 6. Aminoglycoside treatment and mortality after bacteraemia in patients given appropriate empirical therapy: a Danish hospital-based cohort study.
    Freundlich M, Thomsen RW, Pedersen L, West H, Schønheyder HC.
    J Antimicrob Chemother; 2007 Nov 14; 60(5):1115-23. PubMed ID: 17881632
    [Abstract] [Full Text] [Related]

  • 7. Clinical characterization of breakthrough bacteraemia: a survey of 392 episodes.
    López Dupla M, Martinez JA, Vidal F, Almela M, López J, Marco F, Soriano A, Richart C, Mensa J.
    J Intern Med; 2005 Aug 14; 258(2):172-80. PubMed ID: 16018794
    [Abstract] [Full Text] [Related]

  • 8. Favourable outcomes in episodes of Pseudomonas bacteraemia when associated with tunnelled cuffed catheters (TCCs) in chronic haemodialysis patients.
    Golestaneh L, Laut J, Rosenberg S, Zhang M, Mokrzycki MH.
    Nephrol Dial Transplant; 2006 May 14; 21(5):1328-33. PubMed ID: 16421157
    [Abstract] [Full Text] [Related]

  • 9. Gram-negative bacteremia upon hospital admission: when should Pseudomonas aeruginosa be suspected?
    Schechner V, Nobre V, Kaye KS, Leshno M, Giladi M, Rohner P, Harbarth S, Anderson DJ, Karchmer AW, Schwaber MJ, Carmeli Y.
    Clin Infect Dis; 2009 Mar 01; 48(5):580-6. PubMed ID: 19191643
    [Abstract] [Full Text] [Related]

  • 10. Epidemiology and clinical outcome of enterococcal bacteraemia in an acute care hospital.
    Poh CH, Oh HM, Tan AL.
    J Infect; 2006 May 01; 52(5):383-6. PubMed ID: 16203039
    [Abstract] [Full Text] [Related]

  • 11. Impact of antibiotic resistance and of adequate empirical antibiotic treatment in the prognosis of patients with Escherichia coli bacteraemia.
    Peralta G, Sánchez MB, Garrido JC, De Benito I, Cano ME, Martínez-Martínez L, Roiz MP.
    J Antimicrob Chemother; 2007 Oct 01; 60(4):855-63. PubMed ID: 17644532
    [Abstract] [Full Text] [Related]

  • 12. Pseudomonas aeruginosa bacteremia: risk factors for mortality and influence of delayed receipt of effective antimicrobial therapy on clinical outcome.
    Kang CI, Kim SH, Kim HB, Park SW, Choe YJ, Oh MD, Kim EC, Choe KW.
    Clin Infect Dis; 2003 Sep 15; 37(6):745-51. PubMed ID: 12955633
    [Abstract] [Full Text] [Related]

  • 13. Mortality risk factors of Acinetobacter baumannii bacteraemia.
    Choi JY, Park YS, Kim CO, Park YS, Yoon HJ, Shin SY, Kim YA, Song YG, Yong D, Lee K, Kim JM.
    Intern Med J; 2005 Oct 15; 35(10):599-603. PubMed ID: 16207259
    [Abstract] [Full Text] [Related]

  • 14. Predictors of 30-day mortality among patients with Pseudomonas aeruginosa bloodstream infections: impact of delayed appropriate antibiotic selection.
    Lodise TP, Patel N, Kwa A, Graves J, Furuno JP, Graffunder E, Lomaestro B, McGregor JC.
    Antimicrob Agents Chemother; 2007 Oct 15; 51(10):3510-5. PubMed ID: 17646415
    [Abstract] [Full Text] [Related]

  • 15. Association between Enterococcus bacteraemia and death in neutropenic patients with haematological malignancies.
    Todeschini G, Tecchio C, Borghero C, D'Emilio A, Pegoraro E, de Lalla F, Benedetti P, Spolaore P, Pellizzer G.
    J Infect; 2006 Oct 15; 53(4):266-73. PubMed ID: 16388852
    [Abstract] [Full Text] [Related]

  • 16. [Clinical analysis of Pseudomonas aeruginosa bacteremia].
    Kumasaka K, Hosokawa N, Yanai M, Yagoshi M, Simoguchi K, Kawano K.
    Rinsho Byori; 1999 Nov 15; 47(11):1064-9. PubMed ID: 10590685
    [Abstract] [Full Text] [Related]

  • 17. Factors influencing survival in patients with multi-drug-resistant Acinetobacter bacteraemia.
    Metan G, Sariguzel F, Sumerkan B.
    Eur J Intern Med; 2009 Sep 15; 20(5):540-4. PubMed ID: 19712862
    [Abstract] [Full Text] [Related]

  • 18. Pseudomonas aeruginosa bacteraemia in Enugu, Nigeria. A review of 24 cases.
    Ozumba UC.
    Trop Geogr Med; 1995 Sep 15; 47(5):193-6. PubMed ID: 8553439
    [Abstract] [Full Text] [Related]

  • 19. Effects of an alternative cefepime dosing strategy in pulmonary and bloodstream infections caused by Enterobacter spp, Citrobacter freundii, and Pseudomonas aeruginosa: a single-center, open-label, prospective, observational study.
    Deal EN, Micek ST, Reichley RM, Ritchie DJ.
    Clin Ther; 2009 Feb 15; 31(2):299-310. PubMed ID: 19302902
    [Abstract] [Full Text] [Related]

  • 20. Epidemiology and prognostic determinants of bacteraemic biliary tract infection.
    Ortega M, Marco F, Soriano A, Almela M, Martínez JA, López J, Pitart C, Mensa J.
    J Antimicrob Chemother; 2012 Jun 15; 67(6):1508-13. PubMed ID: 22408140
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.